⌘K

Login Start Free

Home/Filings/4/0001600132-18-000072

4//SEC Filing

Tasse Daniel 4

Accession 0001600132-18-000072

CIK 0001600132other

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 4:53 PM ET

Size

5.2 KB

Accession

0001600132-18-000072

Insider Transaction Report

Form 4

Period: 2018-06-05

Bellerophon Therapeutics, Inc.BLPH

Director

Transactions

Award
Stock Option (right to buy)
2018-06-05$2.27/sh+38,216$86,750→ 58,216 total
Exercise: $2.27From: 2019-06-05Exp: 2028-06-04→ Common Stock (38,216 underlying)

Documents

1 file

4
wf-form4_152840478940399.xmlPrimary
FORM 4

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1

filerCIK 0001502785

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 4:53 PM ET
Size: 5.2 KB

View on SEC.gov